CHICAGO -- Adjuvant cemiplimab (Libtayo) significantly improved disease-free survival (DFS) compared with placebo in patients ...

Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre, discusses a novel adjuvant ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

Ty Labbe, a retired homicide detective from the Los Angeles County Sheriff’s Department, faced one of the toughest battles of ...

One in five Americans is likely to get skin cancer in their lifetime, making it the most common type of cancer in the U.S.